Nanopath


Nanopath is dedicated to developing innovative diagnostic technologies to improve women's health globally. They focus on creating a first-in-class molecular diagnostic platform for scalable, point-of-care disease diagnosis, especially targeting pelvic and gynecologic infections. Their mission is to impact human health through interdisciplinary science and engineering, reimagining diagnostic workflows to provide lab-quality results at the point of care, and addressing complex biological needs of women.

Industries

biotechnology

Nr. of Employees

small (1-50)

Nanopath

Cambridge, Massachusetts, United States, North America


Products

Cartridge-and-reader point-of-care diagnostic system

A diagnostic system composed of single-use assay cartridges and a reader device designed to perform multiplexed molecular and biosensor-based tests at the point-of-patient, delivering rapid, lab-quality results.


Services

Integrated diagnostic assay development

Development of molecular and biosensor-based assays targeting pelvic/gynecologic infections, urinary tract infections, HPV, vaginitis, and STIs for integration into point-of-care platforms.

Development partnerships and commercialization collaborations

Engagement in commercial and development partnerships to expand reach and translate diagnostic technologies into clinical and global settings.

Expertise Areas

  • Point-of-care diagnostics development
  • Assay development for infectious diseases
  • Biosensor engineering
  • Nanotechnology for diagnostics
  • Show More (5)

Key Technologies

  • Nanotechnology-based biosensing
  • Optical biosensing
  • Amplification-free molecular detection
  • Multiplexed pathogen detection
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.